Ascendis Pharma A/S
NasdaqGS:ASND
$ 121.12
$-1.68 (-1.37%)
$ 121.12
$-1.68 (-1.37%)
End-of-day quote: 05/17/2024

Ascendis Pharma A/S financials at a glance

The revenue of Ascendis Pharma A/S is reported as 0.26672 billion Dollars in the fiscal year 2023. The earnings were -8.55 Dollars per share in 2023, which was 17.79 higher than 2022. And about -0.4698 billion Dollars are reported as free cash flow in the financials of Ascendis Pharma A/S 2023. No dividends were paid to the shareholders of the Ascendis Pharma A/S stock NasdaqGS:ASND in the financial year 2023.

$266.72M
Revenue
$-8.55
Earnings Per Share
83.36%
Gross Margin %
$-,462.15M
Free Cash Flow
Revenue
266.72
Earnings Per Share
-8.55
Gross Margin %
83.36
Free Cash Flow
-,462.15

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Rev. Revenue N/A $266.72M $51.17M $7.78M $6.95M $13.38M $10.58M $1.53M $4.61M $8.12M $13.98M
GM % Gross Margin % 80.22% 83.36% 76.28% 54.71% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
OM Operating Margin 0.00% -,170.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -85.74%
EPS Earnings Per Share $-10.72 $-8.55 $-10.40 $-7.00 $-8.28 $-4.69 $-3.17 $-3.68 $-2.58 $-1.39 $-1.07
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
Sha. Shares N/AM 56.61M 56.04M 56.78M 53.75M 47.99M 42.14M 41.52M 32.42M 25.13M 23.84M
OCF Operating Cash Flow N/A $-,467.36M $-,495.70M $-,417.65M $-,271.55M $-,185.00M $-,143.03M $-,101.10M $-64.25M $-39.55M $0.00M
FCF Free Cash Flow N/A $-,462.15M $-,510.19M $-,441.35M $-,291.41M $-,190.16M $-,145.68M $-96.04M $-60.85M $-44.51M $0.00M
FCFS Free Cash Flow Per Share $-10.21 $-8.35 $-9.10 $-8.07 $-5.79 $-3.89 $-3.44 $-2.86 $-2.29 $-1.87 $-1.65